Table 3 Anatomic sites of infection and the five most common antimicrobial drugs (ATC level 5) prescribed
From: Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey
Anatomic sitesa | Top 5 antibiotic use (ATCa level 5) among paediatric patients | ||||
|---|---|---|---|---|---|
1st | 2nd | 3rd | 4th | 5th | |
Resp (n = 196) | Gentamicin (n = 35, 17.9%) | Cefuroxime (n = 34, 17.3%) | Ceftriaxone (n = 29, 14.8%) | Amox-clav (n = 18, 9.2%) | Cloxacillin (n = 12, 6.1%) |
C penicillin | |||||
SSTBJ (n = 131) | Metronidazole (n = 24,18.3%) | Cloxacillin (n = 23, 17.6%) | Clindamycin (n = 20, 15.3%) | Cefuroxime (n = 19, 14.5%) | Amox-clav (n = 17, 13.0%) |
GIT (n = 88) | Metronidazole (n = 29, 32.9%) | Cefuroxime (n = 17,19.3%) | Ciprofloxacin (n = 13,14.8%) | Ceftriaxone (n = 11,12.5%) | Gentamicin (n = 7, 8.0%) |
GUOB (n = 33) | Metronidazole (n = 8,24.2%) | Amox-clav (n = 7, 21.2%) | Cefuroxime (n = 5, 15.2%) | Ceftriaxone (n = 4, 12.1%) | Ciprofloxacin (n = 3, 9.1%) |
CNS (n = 26) | Amox-clava (n = 2, 7.7%) | Ceftriaxone (n = 11, 3.4%) | Cloxacillin (n = 5, 1.5%) | Metronidazole (n = 3,0.9%) | Gentamicin (n = 1, 0.3%) |
Cefuroxime | Cefotaxime | ||||
Meropenem | |||||
UTI (n = 14) | Cefuroxime (n = 5, 35.7%) | Ciprofloxacin (n = 3, 21.4%) | Other drugsb (n = 6, 43.8%) | – | – |
Other sites (n = 15) | Ceftriaxone (n = 4, 26.6%) | Amox-clav (n = 2, 13.1%) | Other drugsc (n = 4, 26.6%) | – | – |
C penicillina | |||||
UND (n = 328) | Gentamicin (n = 59,18.0%) | Ceftriaxone (n = 57, 17.4%) | Ampicillin (n = 45,13.7%) | Cloxacillin (n = 42,12.8%) | Amikacin (n = 25,7.6%) |